A promising investigational therapeutic monoclonal antibody to treat chronic hepatitis B and D infections
08-Aug-2023 -
Affecting hundreds of millions of people, chronic hepatitis B is a widespread global health problem for which there is as yet no cure. In a preclinical study involving the German Center for Infection Research (DZIF), Heidelberg University Hospital, University Medical Center Hamburg-Eppendorf and ...
chronic hepatitis B
hepatitis B
hepatitis D
+2